Document Detail


Technetium 99m sestamibi in the assessment of chronic coronary artery disease.
MedLine Citation:
PMID:  1835137     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Extensive work has already been performed with regard to both planar and single photon emission computed (SPECT) technetium 99m sestamibi studies. Before widespread application of optimized acquisition and processing methods, clinical results between 99mTc sestamibi and thallium 201 were remarkably similar. It is anticipated that as techniques for 99mTc sestamibi planar and SPECT imaging become optimized, improvements in sensitivity and specificity for detection of coronary artery disease, over those observed with 201TI, might be forthcoming. This expectation is based on the improved image quality inherent in the use of the 99mTc agent with its higher count rate and higher energy. This improvement in image quality may be a principal reason for laboratories to switch from 201TI to 99mTc sestamibi imaging. It is anticipated that, with improved imaging characteristics, it will be easier for the average community hospital to obtain higher quality planar or SPECT imaging using 99mTc sestamibi rather than 201TI. In addition to improved image quality, the characteristics of 99mTc sestamibi allow gated planar or SPECT perfusion images to be obtained. It has been suggested that stress-gated SPECT sestamibi studies may provide all the information contained in a stress-rest nongated 99mTc sestamibi study, thereby potentially increasing patient throughput, a major concern with SPECT. Throughput can also be increased by using dual-isotope approaches with rest 201TI and stress technetium sestamibi acquisitions, employing either separate or simultaneous imaging with which the entire study can be accomplished in less than 2 hours. With simultaneous dual-isotope acquisition, camera time can be reduced by 50%. Finally, 99mTc sestamibi offers the advantage of the ability to perform first-pass exercise ventricular function and SPECT myocardial perfusion studies with a single injection of tracer. Regarding the assessment of myocardial viability, results to date suggest a very high degree of concordance between 201TI and 99mTc sestamibi studies using either planar or SPECT acquisition techniques. Correlative rest studies with both tracers will be of particular interest, as will preoperative and postoperative and position emission tomography correlation studies.
Authors:
D S Berman; H Kiat; K Van Train; E Garcia; J Friedman; J Maddahi
Related Documents :
8708787 - Collimator design for improved spatial resolution in spect and planar scintigraphy.
11194287 - Detecting viable hibernating myocardium in chronic coronary artery disease--a compariso...
2636247 - Detection of transmural myocardial infarction by single-photon emission computed tomogr...
10439177 - Viable tissue in an area of severely reduced perfusion demonstrated with i-123 iomazeni...
3434787 - The growth of ordered two-dimensional sheets of ribosomal particles from salt-alcohol m...
22847217 - Lsi-based amperometric sensor for bio-imaging and multi-point biosensing.
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Seminars in nuclear medicine     Volume:  21     ISSN:  0001-2998     ISO Abbreviation:  Semin Nucl Med     Publication Date:  1991 Jul 
Date Detail:
Created Date:  1991-11-27     Completed Date:  1991-11-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  1264464     Medline TA:  Semin Nucl Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  190-212     Citation Subset:  IM    
Affiliation:
Department of Nuclear Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Chronic Disease
Coronary Disease / radionuclide imaging*
Heart / radionuclide imaging*
Humans
Multicenter Studies as Topic
Nitriles / diagnostic use*
Organotechnetium Compounds / diagnostic use*
Technetium Tc 99m Sestamibi
Tomography, Emission-Computed, Single-Photon / methods
Grant Support
ID/Acronym/Agency:
1 RO1-HL41628-01/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Nitriles; 0/Organotechnetium Compounds; 109581-73-9/Technetium Tc 99m Sestamibi
Comments/Corrections
Comment In:
Semin Nucl Med. 1991 Jul;21(3):170-2   [PMID:  1835135 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Physiological basis of myocardial perfusion imaging with the technetium 99m agents.
Next Document:  Technetium 99m sestamibi in the assessment of acute myocardial infarction.